HOUSTON, TX, April 21, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced its support for the Health Tech Investment Act (S.
:max_bytes(150000):strip_icc()/VWH-DI-Longevity-GutHealth-9dcf7e4e6b12452d9d1b3bb4dcfbd37b.jpg "Want to Boost Brain Health? Focus on Your Gut")